R13 ADRENAL
NDC 63479-1813, ACTIVATED CHARCOAL, CAUSTICUM, ARABICA COFFEE BEAN, PRASTERONE, GLYCYRRHIZA GLABRA, RIBES NIGRUM FLOWER BUD, ELEUTHERO, and VERATRUM ALBUM ROOT, solution, from Apex Energetics Inc..
- Product NDC
- 63479-1813
- Status
- Listed
- Labeler
- Apex Energetics Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63479-1813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACTIVATED CHARCOAL7 [hp_C]/mL
- CAUSTICUM1 [hp_Q]/mL
- ARABICA COFFEE BEAN7 [hp_C]/mL
- PRASTERONE3 [hp_Q]/mL
- GLYCYRRHIZA GLABRA6 [hp_C]/mL
- RIBES NIGRUM FLOWER BUD1 [hp_X]/mL
- ELEUTHERO1 [hp_C]/mL
- VERATRUM ALBUM ROOT7 [hp_C]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Plant Proteins [CS]; Seed Storage Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63479-1813-1 | 63479181301 | 30 mL in 1 BOTTLE, GLASS (63479-1813-1) |
| 63479-1813-2 | 63479181302 | 30 mL in 1 BOTTLE, GLASS (63479-1813-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63479-1813 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63479-1813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63479-1813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.